Get the Stockscreener App
1.09
2.83%
0.03
Alterity Therapeutics Ltd Adr Stock (ATHE) Forecast
The Alterity Therapeutics Ltd Adr (ATHE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.7583, representing a +244.80% increase from the current price of $1.09. The highest analyst price target is $3.7648, and the lowest is $3.7518.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATHE Price Target
Average 20.83
(+1,811% Upside)
Is Alterity Therapeutics Ltd Adr (ATHE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.46 | Neutral |
| STOCH(9,6) | 17.81 | Buy |
| STOCHRSI(14) | 63.58 | Neutral |
| MACD(12,26) | -0.042 | Sell |
| ADX(14) | 14.25 | Neutral |
| William %R | -69.20 | Neutral |
| CCI(14) | -61.24 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.088
Buy
|
1.0909
Sell
|
| MA20 |
1.1307
Sell
|
1.1227
Sell
|
| MA50 |
1.2089
Sell
|
1.2056
Sell
|
| MA100 |
1.3437
Sell
|
1.3522
Sell
|
| MA200 |
1.6457
Sell
|
1.6262
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, ATHE could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ATHE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.46 indicates that ATHE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 17.81 indicates that ATHE is oversold. This indicates that ATHE price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 63.58 indicates that ATHE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.25 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -61.24 indicates that ATHE is still oversold but not to an extreme extent.
Long-term ATHE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Alterity Therapeutics Ltd Adr financial reports and earnings history, Alterity Therapeutics Ltd Adr (ATHE) stock could reach $15.14 by 2030, $11.35 by 2040 and $29.82 by 2050. See the projected annual prices until 2050 of the Alterity Therapeutics Ltd Adr stock below:
- Alterity Therapeutics Ltd Adr (ATHE) is expected to reach an average price of $4.4127 in 2035, with a high prediction of $4.2789 and a low estimate of $3.9997. This indicates an $304.84% rise from the last recorded price of $1.09.
- Alterity Therapeutics Ltd Adr (ATHE) stock is projected to chart a bullish course in 2040, with an average price target of $11.03, representing an $911.95% surge from its current level. The forecast ranges from a conservative $11.26 to a sky-high $11.35.
- Our analysts predict Alterity Therapeutics Ltd Adr (ATHE) to jump 1,687% by 2045, soaring from $19.15 to an average price of $19.48, potentially reaching $19.56. While $19.15 is the low estimate, the potential upside is significant.
- Alterity Therapeutics Ltd Adr (ATHE) stock is expected to climb by 2050, reaching an average of $29.95, a $2,648% jump from its current level. However, a wide range of estimates exists, with high and low targets of $29.82 and $30.05, respectively, highlighting the market's uncertainty.
Alterity Therapeutics Ltd Adr Stock (ATHE) Year by Year Forecast
Alterity Therapeutics Ltd Adr Stock (ATHE) Price Forecast for 2024
Our forecast for ATHE stock price in 2024 now indicates an average price target of $2.6565 with a high forecast of $4.50 and a low forecast of $0.813. The average prediction reflects an increase of +143.72% from the last recorded price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $4.2028 | $3.7518 | $3.7648 | +285.58% |
Alterity Therapeutics Ltd Adr Stock (ATHE) Price Forecast for 2025
Alterity Therapeutics Ltd Adr Stock (ATHE) is expected to reach an average price of $20.64 in 2025, with a high prediction of $39.93 and a low estimate of $1.3402. This indicates an +1,793% rise from the last recorded price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.3233 | $5.1343 | $4.7943 | +388.38% |
| February, 2025 | $4.8734 | $5.2424 | $4.8769 | +347.10% |
| March, 2025 | $6.6994 | $5.4929 | $5.1114 | +514.62% |
| April, 2025 | $6.482 | $6.982 | $6.5699 | +494.67% |
| May, 2025 | $5.808 | $6.108 | $5.6515 | +432.84% |
| June, 2025 | $6.274 | $5.621 | $5.433 | +475.60% |
| July, 2025 | $5.7556 | $6.3166 | $6.0036 | +428.03% |
| August, 2025 | $2.1574 | $1.7274 | $11.71 | +97.93% |
| September, 2025 | $13.98 | $1.9314 | $39.93 | +1,183% |
| October, 2025 | $8.1488 | $6.9488 | $17.87 | +647.60% |
| November, 2025 | $9.0228 | $7.2793 | $13.64 | +727.78% |
| December, 2025 | $1.4402 | $1.3402 | $11.24 | +32.13% |
Alterity Therapeutics Ltd Adr Stock (ATHE) Price Forecast for 2026
The predicted value for Alterity Therapeutics Ltd Adr (ATHE) in 2026 is set at an average of $12.50. Estimates vary from a peak of $24.97 to a trough of $0.0272, indicating an +1,047% surge from the present price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.7142 | $0.0272 | $24.97 | +332.50% |
| February, 2026 | $3.5882 | $2.9242 | $5.5012 | +229.19% |
| March, 2026 | $5.5621 | $2.6251 | $8.4621 | +410.29% |
| April, 2026 | $8.8796 | $5.8056 | $14.54 | +714.64% |
| May, 2026 | $6.1536 | $2.5676 | $9.1751 | +464.55% |
| June, 2026 | $4.0275 | $3.7275 | $6.497 | +269.50% |
| July, 2026 | $2.745 | $1.545 | $6.958 | +151.83% |
| August, 2026 | $4.5189 | $1.6885 | $5.9189 | +314.58% |
| September, 2026 | $7.5364 | $3.2059 | $18.19 | +591.41% |
| October, 2026 | $5.0604 | $3.4234 | $9.1104 | +364.25% |
| November, 2026 | $4.6843 | $3.6973 | $5.4528 | +329.75% |
| December, 2026 | $3.9518 | $3.6583 | $5.1583 | +262.55% |
Alterity Therapeutics Ltd Adr Stock (ATHE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Alterity Therapeutics Ltd Adr (ATHE) is $2.6763, with a high forecast of $5.3192 and a low forecast of $0.0333. This indicates an +145.53% increase from the last price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.9757 | $3.6453 | $4.9757 | +264.75% |
| February, 2027 | $2.4497 | $1.8497 | $5.3192 | +124.74% |
| March, 2027 | $0.6872 | $0.0723 | $2.6932 | -36.96% |
| April, 2027 | $0.1591 | $0.0333 | $4.2976 | -85.40% |
| May, 2027 | $1.3051 | $0.3716 | $1.7151 | +19.73% |
| June, 2027 | $0.2475 | $0.3024 | $2.7586 | -77.30% |
| July, 2027 | $0.8965 | $0.037 | $1.0065 | -17.75% |
| August, 2027 | $0.4305 | $0.1805 | $1.4235 | -60.51% |
| September, 2027 | $0.2351 | $0.1855 | $1.4544 | -78.43% |
| October, 2027 | $0.8281 | $0.4086 | $1.0719 | -24.03% |
| November, 2027 | $0.2286 | $0.5216 | $0.2459 | -79.02% |
| December, 2027 | $0.4117 | $0.5107 | $0.2198 | -62.23% |
Alterity Therapeutics Ltd Adr Stock (ATHE) Price Forecast for 2028
In 2028, Alterity Therapeutics Ltd Adr (ATHE) is projected to reach an average price of $1.337, with a high projection of $2.0809 and a low estimate of $0.5932. This indicates an +22.66% rise from the last price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4687 | $0.5932 | $0.3503 | -57.00% |
| February, 2028 | $1.6878 | $0.6257 | $1.2888 | +54.84% |
| March, 2028 | $1.9423 | $1.6353 | $1.7723 | +78.19% |
| April, 2028 | $2.0953 | $2.1408 | $1.8843 | +92.23% |
| May, 2028 | $2.4429 | $2.0104 | $2.0809 | +124.12% |
| June, 2028 | $1.3559 | $1.3834 | $1.8544 | +24.40% |
| July, 2028 | $1.432 | $1.3154 | $1.2474 | +31.37% |
| August, 2028 | $1.6345 | $1.8644 | $1.7015 | +49.95% |
| September, 2028 | $1.9305 | $2.1005 | $1.8705 | +77.11% |
| October, 2028 | $1.5266 | $1.9416 | $1.697 | +40.05% |
| November, 2028 | $1.5041 | $1.6791 | $1.5261 | +37.99% |
| December, 2028 | $1.3829 | $1.4186 | $1.3556 | +26.88% |
Alterity Therapeutics Ltd Adr Stock (ATHE) Price Forecast for 2029
The 2029 price forecast for Alterity Therapeutics Ltd Adr Stock (ATHE) is $5.1003 on average, with a high prediction of $10.20 and a low estimate of $0.000592. This represents an +367.92% increase from the previous price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.0577 | $1.1677 | $1.2589 | -2.96% |
| February, 2029 | $1.1136 | $1.1007 | $0.9308 | +2.17% |
| March, 2029 | $1.0098 | $0.9733 | $0.8803 | -7.36% |
| April, 2029 | $1.0058 | $1.0063 | $0.8778 | -7.72% |
| May, 2029 | $0.8256 | $1.0182 | $0.9735 | -24.25% |
| June, 2029 | $1.3844 | $0.8249 | $1.3144 | +27.01% |
| July, 2029 | $0.3804 | $0.3909 | $2.4091 | -65.10% |
| August, 2029 | $0.543 | $0.692 | $0.6604 | -50.19% |
| September, 2029 | $0.769 | $0.6095 | $0.461 | -29.45% |
| October, 2029 | $0.4915 | $0.6165 | $0.562 | -54.90% |
| November, 2029 | $0.0476 | $0.1776 | $1.0589 | -95.64% |
| December, 2029 | $12.50 | $0.000592 | $10.20 | +1,047% |
Alterity Therapeutics Ltd Adr Stock (ATHE) Price Forecast for 2030
Alterity Therapeutics Ltd Adr Stock (ATHE) is expected to reach an average price of $16.43 in 2030, with a high forecast of $19.14 and a low forecast of $13.71. This signifies an +1,407% surge from the last price of $1.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $15.27 | $13.71 | $15.14 | +1,300% |
| February, 2030 | $16.12 | $15.68 | $15.62 | +1,379% |
| March, 2030 | $18.77 | $17.43 | $18.07 | +1,622% |
| April, 2030 | $16.72 | $17.31 | $18.08 | +1,434% |
| May, 2030 | $16.09 | $16.37 | $16.63 | +1,376% |
| June, 2030 | $15.55 | $16.24 | $16.46 | +1,327% |
| July, 2030 | $17.00 | $15.76 | $16.20 | +1,460% |
| August, 2030 | $16.74 | $17.62 | $17.14 | +1,436% |
| September, 2030 | $18.21 | $18.27 | $17.84 | +1,571% |
| October, 2030 | $18.57 | $18.12 | $17.79 | +1,604% |
| November, 2030 | $19.85 | $18.89 | $18.21 | +1,721% |
| December, 2030 | $18.48 | $19.46 | $19.14 | +1,595% |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):